AIMCA
INDV icon

Alberta Investment Management Corp (AIMCo)’s Indivior Pharmaceuticals INDV Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-124,000
Closed -$3.78M – 692
2026
Q1 		$3.78M Buy
+124,000
New +$4.1M 0.02% 338

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s INDV Position: Q2 2026 in Review

Alberta Investment Management Corp (AIMCo) sold out of Indivior Pharmaceuticals (INDV) in Q2 2026, closing a stake of 124,000 shares — an estimated $3.78M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in INDV in Q1 2026 and held it in 1 quarter. The position peaked at $3.78M in Q1 2026. 125 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Indivior Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 124,000 Indivior Pharmaceuticals shares in Q2 2026, an estimated $3.78M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Indivior Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Indivior Pharmaceuticals position peaked at $3.78M in Q1 2026.
  • 125 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2026, filed 6 Aug 2026.